H
Hiroshi Maeda
Researcher at Kumamoto University
Publications - 915
Citations - 67944
Hiroshi Maeda is an academic researcher from Kumamoto University. The author has contributed to research in topics: Neocarzinostatin & Nitric oxide. The author has an hindex of 103, co-authored 893 publications receiving 63370 citations. Previous affiliations of Hiroshi Maeda include Osaka University & Okayama University.
Papers
More filters
Journal ArticleDOI
Application of Proximity Effect Correction Using Pattern-Area Density to Patterning on a Heavy-Metal Substrate and the Cell-Projection Exposure
TL;DR: Proximity effect correction for electron beam (EB) direct writing is studied in this article, where an iterative calculation of exposure-dose modulation by equalizing the deposited energy of all figures requires an extremely long calculation time.
Book ChapterDOI
Infection, Inflammation, and Cancer Mediated by Oxygen Radicals and Nitric Oxide
Hiroshi Maeda,Takaaki Akaike +1 more
TL;DR: This chapter shows that these completely different factors can be unified by free radicals and nitric oxide derivatives, and presents examples of carcinogenesis caused by the viral and bacterial infections.
Journal ArticleDOI
Antitumor resistance induced by zinostatin stimalamer (ZSS), a polymer-conjugated neocarzinostatin (NCS) derivative. I. Meth A tumor eradication and tumor-neutralizing activity in mice pretreated with ZSS or NCS.
Etsuko Masuda,Hiroshi Maeda +1 more
TL;DR: It is suggested that the cytocidal effect of ZSS involves the induction of hostmediated antitumor resistance, and in athymic Balb/cnu/nu mice, pretreatment with ZSS or NCS did not induce tumor eradication, suggesting that mature T lymphocytes play an important role in tumor eradications.
Journal ArticleDOI
Plasma Cell Granuloma of the Bladder: A Case Report
TL;DR: A case of plasma cell granuloma of the bladder involving the omentum is reported and differential diagnosis with hematoxylin and eosin staining was difficult due to atypical plasma cells.
Journal Article
Changes in cellular components of spleen and lymph node cells and the effector cells responsible for Meth A tumor eradication induced by zinostatin stimalamer.
Etsuko Masuda,Hiroshi Maeda +1 more
TL;DR: The result of ZSS treatment after tumor transplantation suggests that ZSS might exhibit antitumor activity by augementating host-mediated antitumors resistance, as well as its intrinsic cytocidal activity.